Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn

A legfontosabb adatok

Ki végzi
Intressa Vascular SA
Hol
Ausztria, Belgium, Bulgária, Franciaország, Lengyelország, Németország, Szerbia és Üzbegisztán21 helyszín, 8 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
72 fő, tervezett
Kezdés
2024. okt. 30.
Várható befejezés
2031. jún.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Allay Aortic Stent
A regiszteradat frissítve
2026. szeptember 16.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Have a type B aortic dissection extending to the celiac trunk or beyond
  • Are eligible for thoracic endovascular treatment with stent grafts as per local guidelines, and physician's decision
  • Have been elected for treatment with commercially available stent graft as per their IFU within 90 days of dissection symptoms onset

Ki nem vehet részt

  • General Exclusion Criteria:; Age < 18 years; Pregnant, breast-feeding or planning on becoming pregnant during the entire duration of the study; Unable to provide written informed consent; Unable or unwilling to comply with the requirements of the study protocol; Taking part already in an investigational device or drug study that could interfere with the outcomes being studied; Active drug addiction or known history of drug abuse within one year of treatment
  • Medical Exclusion Criteria:; Aortic rupture (free or contained including haemothorax, increasing periaortic hematoma, or mediastinal hematoma); Aortic fistula; Suspicion of bowel necrosis or irreversible visceral ischemia; Stage 5 chronic kidney disease; Life expectancy of less than 2 years due to any other medical condition than the dissection to be treated; Active malignancy; Known sensitivities or allergies to the device materials (including cobalt, chromium, nickel); Known sensitivities or allergies to contrast materials that cannot be pre-medicated; Mycotic aortic aneurysm or active systemic infection that may place the patient at increased risk of endovascular infection; American Society of Anaesthesiologists (ASA) class V (moribund patient not expected to live 24 hours with or without operation); Diagnosed or suspected congenital degenerative connective tissue disease (e.g., Marfan's, Loeys-Dietz or Ehlers-Danlos syndrome); Uncorrectable coagulopathy, bleeding diathesis or refusal of blood transfusion; Any major cardiovascular or cerebrovascular ischemic event, including myocardial infarction or stroke, or treatment of such event, within 90 days prior to enrolment; Any aortic-related interventional or surgical procedure within 30 days prior to enrolment; Any planned aortic-related interventional or surgical procedure within 30 days after the study procedure
  • Anatomical Exclusion Criteria:; Aneurysmal dilatation of the false lumen defined as maximum transaortic diameter >55 mm in women or >60 mm in men in the thoraco-abdominal segment or >50 mm in women or >55 mm in men in the abdominal segment, measured inner-wall to inner-wall; Inadequate proximal landing zone for the stent graft, such zone being <20 mm long; Inadequate proximal landing zone geometry for the Allay® Aortic Stent (e.g. aortic kink); Planned implantation of a stent graft with a distal diameter >38 mm or <20 mm; Aorta or iliac anatomy not allowing the advancement of the delivery system; Subject in whom the thoracic stent graft is either 1) not implanted in its intended position and/or 2) leads to any serious device complication, and/or who has 3) persistent static obstruction of the visceral or both renal arteries, prior to Allay® Aortic Stent implantation, will not be implanted with the Allay® Aortic Stent and will be withdrawn from the study

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

8 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.

A vizsgálat csoportja

  • Allay Aortic StentA vizsgált kezelés

    A covered thoracic stent graft is first deployed in supraceliac position as per standard of care then followed by the implantation of the Allay® Aortic Stent deployed from within the stent graft, extending below the celiac trunk to the end of the dissected aorta, typically the aortoiliac bifurcation.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Clinical Study to Evaluate the Effectiveness and Safety of the Allay® Aortic Stent as Adjunctive Endovascular Treatment of Type B Aortic Dissection in Patients Eligible for Thoracic Endovascular Repair With Stent Grafts
A regiszteradat frissítve
2026. szeptember 16.